This Biotech Stock Winner Is Up 72%, but Trim Signals Reset
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
Determine the index fund with the lowest retirement cost through a concise comparison to guide a cost-aware choice.
28,256 articlesA biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
The U.S. Department of Justice has asked a federal judge to pause Evanston, Illinois’ pioneering reparations program,...
A major fund trimmed Freshworks stock by hundreds of thousands of shares, triggering a 60% year-long drop in the stoc...
Quarterly filings reveal big-money moves. Seven of eight ultra-rich fund managers trimmed a single AI stock that’s su...
Early 2026 shows Asia-led gains outpacing the U.S., with Asia-focused ETFs rising as tech and earnings momentum impro...
A major capital shift is unfolding as chipmakers gain ground while hyperscalers slow. NVIDIA and Micron are set to be...
When a board member sells 7,000 shares, traders and long-term investors want to know why. This article breaks down Fo...
Investors turn to a resilient, income-focused mix to weather headlines and market swings in 2026. A practical framewo...
The cyber threat landscape is expanding, and AI is changing the game. This article explains why the cybersecurity mar...
AI-powered venture activity in Q4 2025 shows a notable revival in healthtech, cybersecurity, biotech, and enterprise ...
Chip optimism propelled tech stocks higher as ceasefire reports sparked relief rallies. This guide breaks down what d...